Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorrit J Hornberg

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Drug Discovery Today. Technologies|October 22, 2013
Finding the way in the jungle of kinase drug targetsEllinor Oxelmark, Jorrit J Hornberg
Chemical Research in Toxicology|October 22, 2016
Advances in Predictive Toxicology for Discovery Safety through High Content ScreeningMikael Persson, Jorrit J Hornberg
Future Medicinal Chemistry|March 22, 2014
How can we discover safer drugs?Jorrit J Hornberg, Tomas Mow
Molecular Biotechnology|December 19, 2006
Oncogenes are to lose control on signaling following mutation: should we aim off target?Jorrit J Hornberg, Hans V Westerhoff
Archives of Toxicology|December 13, 2018
Compound selection and annotation to validate the predictivity of in vitro toxicity assays for use in drug discovery, in response to Commentary by Dr. Zink (Zink, D. Arch Toxicol (2018))Anna-Karin Sjögren, Jorrit J Hornberg
European Journal of Biochemistry|September 18, 2004
Synergistic activation of signalling to extracellular signal-regulated kinases 1 and 2 by epidermal growth factor and 4 beta-phorbol 12-myristate 13-acetateJorrit J Hornberg, Marloes R Tijssen, Jan Lankelma
Journal of Pharmacological and Toxicological Methods|August 13, 2013
A high content screening assay to predict human drug-induced liver injury during drug discoveryMikael Persson, Anni F Løye, Tomas Mow, et al.
Environmental and Molecular Mutagenesis|August 12, 2014
Validation of a high throughput flow cytometric in vitro micronucleus assay including assessment of metabolic activation in TK6 cellsAnnemette V Thougaard, Joan Christiansen, Tomas Mow, et al.
Bio Systems|January 24, 2006
Cancer: a Systems Biology diseaseJorrit J Hornberg, Frank J Bruggeman, Hans V Westerhoff, et al.
Archives of Toxicology|July 20, 2021
Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicityJan G Hengstler, Anna-Karin Sjögren, Daniele Zink, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Drug Discovery Today. Technologies|October 22, 2013
Finding the way in the jungle of kinase drug targetsEllinor Oxelmark, Jorrit J Hornberg
Chemical Research in Toxicology|October 22, 2016
Advances in Predictive Toxicology for Discovery Safety through High Content ScreeningMikael Persson, Jorrit J Hornberg
Future Medicinal Chemistry|March 22, 2014
How can we discover safer drugs?Jorrit J Hornberg, Tomas Mow
Molecular Biotechnology|December 19, 2006
Oncogenes are to lose control on signaling following mutation: should we aim off target?Jorrit J Hornberg, Hans V Westerhoff
Archives of Toxicology|December 13, 2018
Compound selection and annotation to validate the predictivity of in vitro toxicity assays for use in drug discovery, in response to Commentary by Dr. Zink (Zink, D. Arch Toxicol (2018))Anna-Karin Sjögren, Jorrit J Hornberg
European Journal of Biochemistry|September 18, 2004
Synergistic activation of signalling to extracellular signal-regulated kinases 1 and 2 by epidermal growth factor and 4 beta-phorbol 12-myristate 13-acetateJorrit J Hornberg, Marloes R Tijssen, Jan Lankelma
Journal of Pharmacological and Toxicological Methods|August 13, 2013
A high content screening assay to predict human drug-induced liver injury during drug discoveryMikael Persson, Anni F Løye, Tomas Mow, et al.
Environmental and Molecular Mutagenesis|August 12, 2014
Validation of a high throughput flow cytometric in vitro micronucleus assay including assessment of metabolic activation in TK6 cellsAnnemette V Thougaard, Joan Christiansen, Tomas Mow, et al.
Bio Systems|January 24, 2006
Cancer: a Systems Biology diseaseJorrit J Hornberg, Frank J Bruggeman, Hans V Westerhoff, et al.
Archives of Toxicology|July 20, 2021
Correction to: In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicityJan G Hengstler, Anna-Karin Sjögren, Daniele Zink, et al.
Pageof 3